Prof. Dr. AHMET ÜNAL

Yayın Ağı

Makaleler 21

1. Frequency and predictors of coronavirus anxiety in psychiatric patients and healthy people and its effect on treatment compliance during the pandemic

CANSEL N., ÜNAL A., EKİCİ ÖNSÖZ S., AKAN M., GÖNENİR ERBAY L., MELEZ Ş. N. İ.

Medicine Science , cilt.10, sa.4, ss.1433-1440, 2021 (TRDizin) Sürdürülebilir Kalkınma

2. Substance use profile, treatment compliance, treatment outcomes and related factors in probation: a retrospective file review

DEMİR B., Kocamer Şahin Ş., ALTINDAĞ A., ELBOĞA G., ÜNAL A.

JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE , cilt.20, sa.3, ss.490-505, 2021 (SCI-Expanded, SSCI, Scopus)

3. Evaluation of psychiatric consultations requested for cancer patients hospitalized in a university hospital

CANSEL N., ÜNAL A.

Annals of Medical Research , cilt.28, sa.2, ss.390-394, 2021 (TRDizin) Sürdürülebilir Kalkınma

4. Oxidative Metabolism and oxidative DNA damage in bipolar disorder: There ara no difference in acute and euthymic state

ERMİŞ B., SAĞALTICI E., ÜNAL A., ALICI D., ÖZYURT A. B.

PSYCHIATRY AND BEHAVIORAL SCIENCES , cilt.11, sa.4, ss.249-257, 2021 (ESCI)

5. The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia: Treatment Characteristics and Outcomes in 60 Patients.

Unal A., Altindag A., Demir B., Aksoy I.

The journal of ECT , cilt.33, sa.4, ss.290-293, 2017 (SCI-Expanded, SSCI, Scopus)

6. Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder.

Alici D., Bulbul F., Virit O., Unal A., Altindag A., Alpak G., et al.

Psychiatry and clinical neurosciences , cilt.70, sa.2, ss.109-15, 2016 (SCI-Expanded, Scopus)

7. Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients.

Sertan Copoglu U., Virit O., Hanifi Kokacya M., Orkmez M., Bulbul F., Binnur Erbagci A., et al.

Psychiatry research , cilt.229, sa.1-2, ss.200-5, 2015 (SCI-Expanded, SSCI, Scopus)

8. Post-traumatic stress disorder among Syrian refugees in Turkey: a cross-sectional study.

Alpak G., Unal A., Bulbul F., Sagaltici E., Bez Y., Altindag A., et al.

International journal of psychiatry in clinical practice , cilt.19, sa.1, ss.45-50, 2015 (SCI-Expanded, Scopus)

9. Are oxidative stress markers useful to distinguish schizoaffective disorder from schizophrenia and bipolar disorder?

Bulbul F., Virit O., Alpak G., Unal A., Bulut M., Kaya M. C., et al.

Acta neuropsychiatrica , cilt.26, sa.2, ss.120-4, 2014 (SCI-Expanded, Scopus)

10. New molecule in the etiology of schizophrenia: urotensin II.

Bulbul F., Alpak G., Unal A., Copoglu U. S., Orkmez M., Virit O., et al.

Psychiatry and clinical neurosciences , cilt.68, sa.2, ss.133-6, 2014 (SCI-Expanded, Scopus)

11. Electroconvulsive therapy in pregnant patients.

Bulbul F., Copoglu U. S., Alpak G., Unal A., Demir B., Tastan M. F., et al.

General hospital psychiatry , cilt.35, sa.6, ss.636-9, 2013 (SCI-Expanded, SSCI, Scopus)

12. Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy.

Unal A., Bulbul F., Alpak G., Virit O., Copoglu U. S., Savas H. A.

The journal of ECT , cilt.29, sa.3, ss.206-9, 2013 (SCI-Expanded, SSCI, Scopus)

13. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.

Albayrak Y., Ünsal C., Beyazyüz M., Ünal A., Kuloğlu M.

Progress in neuro-psychopharmacology & biological psychiatry , cilt.45, ss.144-9, 2013 (SCI-Expanded, Scopus)

14. Maintenance therapy with electroconvulsive therapy in a patient with a codiagnosis of bipolar disorder and obsessive-compulsive disorder.

Bülbül F., Copoglu U. S., Alpak G., Unal A., Tastan M. F., Savas H. A.

The journal of ECT , cilt.29, sa.2, 2013 (SCI-Expanded, SSCI, Scopus)

15. Persistent catatonia for 1.5 years finally resolved with electroconvulsive therapy.

Bülbül F., Ünal A., Çöpoğlu Ü. S., Alpak G., Savaş H. A.

The journal of ECT , cilt.29, sa.1, 2013 (SCI-Expanded, SSCI, Scopus)

16. Is there any relationship between ADHD symptoms and choosing sports education at the university?

Gökçen C., Unal A., Alpak G., Cöpoglu U. S., Abakay U., Bayar H., et al.

International journal of psychiatry in medicine , cilt.46, sa.2, ss.169-78, 2013 (SCI-Expanded, SSCI, Scopus)

17. Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)?

Öztürk Z. A., Ünal A., Yiğiter R., Yesil Y., Kuyumcu M. E., Neyal M., et al.

Archives of gerontology and geriatrics , cilt.56, sa.1, ss.50-4, 2013 (SCI-Expanded, Scopus)

18. Patient adherence and efficacy of quetiapine treatment in schizophrenia: results of a multicentre, naturalistic 6-month follow-up study.

Alptekin K., Aydin H., Gucer K. M., Dilbaz N., Goka E., Esendemir C., et al.

International clinical psychopharmacology , cilt.25, sa.6, ss.342-8, 2010 (SCI-Expanded, Scopus)

19. Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.

Atmaca M., Kuloglu M., Tezcan E., Unal A.

Human psychopharmacology , cilt.17, sa.8, ss.401-5, 2002 (SCI-Expanded, Scopus)

20. Color and number preferences of patients with psychiatric disorders in eastern Turkey.

Kuloğlu M., Atmaca M., Tezcan A. E., Unal A., Gecici O.

Perceptual and motor skills , cilt.94, sa.1, ss.207-13, 2002 (SSCI, Scopus)

21. "The detergent is circulating in my blood": a case report.

Atmaca M., Kuloglu M., Tezcan E., Unal A.

International journal of psychiatry in clinical practice , cilt.6, sa.2, ss.117-9, 2002 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Metabolic Syndrome in patients with Schizoaffective Disorder and relationship with the antipsychotics.

ŞAHİN Ş., ELBOĞA G., ŞAHİN A. Z., ÜNAL A., KILIÇ O. H. T., ALTINDAĞ A.

9. Uluslararası Psikofarmakoloji Kongresi 5.Uluslararası Çocuk ve Ergen Psikofarmakolojisi Sempozyumu, Türkiye, 26 - 30 Nisan 2017, (Özet Bildiri)

2. Is the neutrophil to lymphocyte ratio indicating inflammation in bipolar disorder

ÜNAL A., SAVAŞ E., SAYİNER Z. A., ALPAK G., DEMİR B., KAYA H., et al.

7. Uluslararası Psikofarmakoloji Kongresi, 15 - 19 Nisan 2015, cilt.25, ss.107

3. A comprehensive retrospective study regarding the efficacy of electroconvulsive therapy in an adolescent population

KARAYAĞMURLU A., ALPAK G., YILDIZ E., HASAN B., BÜLBÜL F., ÜNAL A.

7. Uluslararası Psikofarmakoloji Kongresi, Antalya, Türkiye, 15 - 19 Nisan 2015, cilt.25, ss.206

4. Evaluation of oxidative metabolism and urotensin II levels in patients with bipolar disoprder mania

ALPAK G., BÜLBÜL F., VIRIT O., DEMİR B., ÜNAL A., TARAKÇIOĞLU M., et al.

7. Uluslararası Psikofarmakoloji Kongresi, Antalya, Türkiye, 15 - 19 Nisan 2015, cilt.25, ss.142

Kitaplar 1

1. Bipolar Bozuklukta Psikoterapi

ÜNAL A.

Temel ve Klinik Psikiyatri, Prof. Dr. K. Oğuz Karamustafalıoğlıu, Editör, Güneş Tıp Kitabevleri, Ankara, ss.307-311, 2018

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (Sobiad)

386

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Proje

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler